Mark Rutstein – Biography
Last update: February 20, 2026Executive profile
Mark Rutstein is currently
Head of Global Oncology Clinical Development at Daiichi Sankyo US - View - Daiichi Sankyo US org chart
Create your alert
to follow the career of Mark Rutstein.
More about Mark Rutstein
Do you need to know more about Mark Rutstein? More results.
Participate
Social media
- Mark Rutstein on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Rutstein
The colleagues of Mark Rutstein
Company Colleagues
- At Daiichi Sankyo US, Mark Rutstein has 41 colleagues including Ken Keller (CEO & Oncology), Ken Takeshita (Research & Development)…
Industry Colleagues
- In the Pharmaceuticals industry, Mark Rutstein has 22,990 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Mark Rutstein.
Get in Touch
Here are a few tips for establishing great contacts.
Through the switchboard, call Daiichi Sankyo US at +1 973... and ask for Mark Rutstein.
